WHO's approval to Covaxin will facilitate foreign travel for Indians: EAM S Jaishankar
The World Health Organisation (WHO) had on Wednesday granted emergency use approval for Bharat Biotech's COVID-19 vaccine Covaxin, in a move that the pharma major said is a "significant" step towards ensuring wider global access to the indigenously developed jab.
Trending Photos
New Delhi: External Affairs Minister S Jaishankar has said that the WHO's decision to grant emergency use approval to Bharat Biotech's COVID-19 vaccine Covaxin will facilitate international travel for many Indian citizens and contributes to vaccine equity.
The EAM on Wednesday said that it was also a global recognition of Prime Minister Narendra Modi's vision of an 'Atmanirbhar Bharat'. "Welcome @WHO's decision to grant Emergency Use Listing to #COVAXIN. It facilitates travel for many Indian citizens and contributes to vaccine equity. Also a global recognition to PM @narendramodi's vision of an #AtmanirbharBharat. A Happier Diwali," Jaishankar tweeted.
Welcome @WHO’s decision to grant Emergency Use Listing to #COVAXIN.
It facilitates travel for many Indian citizens and contributes to vaccine equity.
Also a global recognition to PM @narendramodi’s vision of an #AtmanirbharBharat.
A Happier Diwali. — Dr. S. Jaishankar (@DrSJaishankar) November 3, 2021
The World Health Organisation (WHO) had on Wednesday granted emergency use approval for Bharat Biotech's COVID-19 vaccine Covaxin, in a move that the pharma major said is a "significant" step towards ensuring wider global access to the indigenously developed jab.
Earlier, the UN health body panel had sought additional clarifications from the manufacturer of Covaxin, in order to conduct a final EUL risk-benefit assessment for global use of the vaccine.
The approval was done on the recommendation of the Technical Advisory Group (TAG) for Emergency Use Listing (TAG-EUL), an independent advisory panel that provides recommendations to WHO on whether a COVID-19 vaccine can be listed for emergency use under the EUL procedure.
Bharat Biotech`s Covaxin and AstraZeneca and Serum Institute`s Covishield are the two widely used vaccines in India.
Following the World Health Organization`s (WHO) Emergency Use Listing (EUL) for Bharat Biotech`s COVID-19 vaccine, Covaxin, Indian Council of Medical Research (ICMR) Director General Balram Bhargava on Wednesday said the approval has now opened up the indigenous vaccine for worldwide use.
Stay informed on all the latest news, real-time breaking news updates, and follow all the important headlines in india news and world News on Zee News.
Live Tv